Nephros (NASDAQ:NEPH) Receives Speculative Buy Rating from Benchmark

Benchmark reiterated their speculative buy rating on shares of Nephros (NASDAQ:NEPH) in a report published on Tuesday, MarketBeat reports. They currently have a $5.00 price objective on the stock.

Nephros Stock Performance

NASDAQ NEPH opened at $1.56 on Tuesday. The firm’s 50 day moving average price is $1.60 and its two-hundred day moving average price is $1.92. Nephros has a twelve month low of $1.36 and a twelve month high of $4.04. The stock has a market cap of $16.45 million, a price-to-earnings ratio of -17.33 and a beta of 1.19.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Nephros stock. Dimensional Fund Advisors LP bought a new stake in shares of Nephros, Inc. (NASDAQ:NEPH) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 17,631 shares of the company’s stock, valued at approximately $37,000. Dimensional Fund Advisors LP owned approximately 0.17% of Nephros at the end of the most recent reporting period. Hedge funds and other institutional investors own 41.10% of the company’s stock.

About Nephros

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.